| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 99.22 | 21.7% | 121.7% |
| Total Income | 99.22 | 21.7% | 121.7% |
| Expenditure | 90.69 | 5.7% | 8.2% |
| PBT | — | ||
| Net Profit | 7.41 | 146.6% | 117.8% |
| OPM | 8.59% | 26.52pp | 95.88pp |
| NPM | 7.47% | 26.96pp | 100.28pp |
| EPS | 0.06 | 146.2% | 118.2% |
Arcutis Biotherapeutics Announces Q3 2025 Financial Results
04 May 2026 · 4 May, 8:43 am
Summary
Arcutis Biotherapeutics, Inc. issued a press release on October 28, 2025, outlining its strategy for driving sustainable growth and announcing its financial results for the quarter ended September 30, 2025.
Informational and educational content only. Not investment advice.